Skip to main content
Clinical Trials/NL-OMON45173
NL-OMON45173
Recruiting
Phase 3

Clinical and health economic evaluation with a new Baha® abutment design combined with a minimally invasive surgical technique - CBAS5439

COCHLEAR BONE ANCHORED SOLUTIONS AB0 sites63 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
COCHLEAR BONE ANCHORED SOLUTIONS AB
Enrollment
63
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Trial is onging in other countries

Registry
who.int
Start Date
TBD
End Date
September 15, 2017
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \* Adult patient, i.e. \* 18 years of age
  • \* Eligible for the Baha system
  • \* Signed informed consent

Exclusion Criteria

  • \* Patient scheduled for simultaneously bilateral implant surgery
  • \* Uncontrolled diabetes as judged by the investigator
  • \* Condition that could jeopardize osseointegration and/or wound healing, e.g. osteoporosis, psoriasis and use of corticosteroids
  • \* Unable to follow the cleaning instruction
  • \* Unable to follow investigational procedures, e.g. to complete quality of life scales
  • \* Participation in another investigation with pharmaceuticals and/or device
  • \* Condition that may have an impact on the outcome of the investigation as judged by the investigator
  • \* Suitable implant position for the 4 mm implant not found during surgery due to insufficient bone quality and/or bone thickness

Outcomes

Primary Outcomes

Not specified

Similar Trials